These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

368 related articles for article (PubMed ID: 38226207)

  • 1. Overview of processed excipients in ocular drug delivery: Opportunities so far and bottlenecks.
    Ashique S; Mishra N; Mohanto S; Gowda BHJ; Kumar S; Raikar AS; Masand P; Garg A; Goswami P; Kahwa I
    Heliyon; 2024 Jan; 10(1):e23810. PubMed ID: 38226207
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Biodegradable Polymer-Based Drug-Delivery Systems for Ocular Diseases.
    Tsung TH; Tsai YC; Lee HP; Chen YH; Lu DW
    Int J Mol Sci; 2023 Aug; 24(16):. PubMed ID: 37629157
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Strategies to prolong the residence time of drug delivery systems on ocular surface.
    Grassiri B; Zambito Y; Bernkop-Schnürch A
    Adv Colloid Interface Sci; 2021 Feb; 288():102342. PubMed ID: 33444845
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recent advances in ocular drug delivery.
    Achouri D; Alhanout K; Piccerelle P; Andrieu V
    Drug Dev Ind Pharm; 2013 Nov; 39(11):1599-617. PubMed ID: 23153114
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hyaluronan as a promising excipient for ocular drug delivery.
    Guter M; Breunig M
    Eur J Pharm Biopharm; 2017 Apr; 113():34-49. PubMed ID: 27914235
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipid-Based Nanoparticulate Systems for the Ocular Delivery of Bioactives with Anti-Inflammatory Properties.
    Ana RD; Fonseca J; Karczewski J; Silva AM; Zielińska A; Souto EB
    Int J Mol Sci; 2022 Oct; 23(20):. PubMed ID: 36292951
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Considerations for Polymers Used in Ocular Drug Delivery.
    Allyn MM; Luo RH; Hellwarth EB; Swindle-Reilly KE
    Front Med (Lausanne); 2021; 8():787644. PubMed ID: 35155469
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Complex Coacervates as a Promising Vehicle for mRNA Delivery: A Comprehensive Review of Recent Advances and Challenges.
    Forenzo C; Larsen J
    Mol Pharm; 2023 Sep; 20(9):4387-4403. PubMed ID: 37561647
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Lipid nanoparticles (SLN, NLC): Overcoming the anatomical and physiological barriers of the eye - Part II - Ocular drug-loaded lipid nanoparticles.
    Sánchez-López E; Espina M; Doktorovova S; Souto EB; García ML
    Eur J Pharm Biopharm; 2017 Jan; 110():58-69. PubMed ID: 27789359
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Solid lipid excipients - matrix agents for sustained drug delivery.
    Rosiaux Y; Jannin V; Hughes S; Marchaud D
    J Control Release; 2014 Aug; 188():18-30. PubMed ID: 24929038
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Overview of Recent Advances in Nano-Based Ocular Drug Delivery.
    Liu LC; Chen YH; Lu DW
    Int J Mol Sci; 2023 Oct; 24(20):. PubMed ID: 37895032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Excipients in parenteral formulations: selection considerations and effective utilization with small molecules and biologics.
    Rayaprolu BM; Strawser JJ; Anyarambhatla G
    Drug Dev Ind Pharm; 2018 Oct; 44(10):1565-1571. PubMed ID: 29863908
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug Delivery for Ocular Allergy: Current Formulation Design Strategies and Future Perspectives.
    Regu VR; Swain RP; Subudhi BB
    Curr Pharm Des; 2023; 29(33):2626-2639. PubMed ID: 37936454
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Overview on zein protein: a promising pharmaceutical excipient in drug delivery systems and tissue engineering.
    Labib G
    Expert Opin Drug Deliv; 2018 Jan; 15(1):65-75. PubMed ID: 28662354
    [TBL] [Abstract][Full Text] [Related]  

  • 15. An Overview of Recent Patents and Patented Technology Platforms Based on Co-Processed Excipients.
    Kaushik D; Goel E; Verma R; Pandey P; Purohit D; Mittal V; Kumar K; Rahman MH
    Recent Adv Drug Deliv Formul; 2021; 15(1):3-14. PubMed ID: 33397276
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Rediscovering Tocophersolan: A Renaissance for Nano-Based Drug Delivery and Nanotheranostic Applications.
    Wande DP; Cui Q; Chen S; Xu C; Xiong H; Yao J
    Curr Drug Targets; 2021; 22(8):856-869. PubMed ID: 32525772
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cellulose nanofibers as excipient for the delivery of poorly soluble drugs.
    Löbmann K; Svagan AJ
    Int J Pharm; 2017 Nov; 533(1):285-297. PubMed ID: 28951349
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Novel nano-cellulose excipient for generating non-Newtonian droplets for targeted nasal drug delivery.
    Young PM; Traini D; Ong HX; Granieri A; Zhu B; Scalia S; Song J; Spicer PT
    Drug Dev Ind Pharm; 2017 Oct; 43(10):1729-1733. PubMed ID: 28581833
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Emerging Trends in Nanomedicine for Improving Ocular Drug Delivery: Light-Responsive Nanoparticles, Mesoporous Silica Nanoparticles, and Contact Lenses.
    Rodrigues FSC; Campos A; Martins J; Ambrósio AF; Campos EJ
    ACS Biomater Sci Eng; 2020 Dec; 6(12):6587-6597. PubMed ID: 33320633
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hypromellose - A traditional pharmaceutical excipient with modern applications in oral and oromucosal drug delivery.
    Mašková E; Kubová K; Raimi-Abraham BT; Vllasaliu D; Vohlídalová E; Turánek J; Mašek J
    J Control Release; 2020 Aug; 324():695-727. PubMed ID: 32479845
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.